News & Events


Journal of the American Geriatrics Society
Racial and ethnic differences in disease course Medicare expenditures for beneficiaries with dementia
Value in Health
It's time to reconsider the three percent discount rate.
Health Affairs Forefront
Are We Valuing Prescription Drugs Appropriately?
Health Policy Open
Variation in Medicaid and commercial coverage of cell and gene therapies
Journal of Alzheimer's Disease
Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life
Health Affairs Forefront
The Case For Including Dynamic Drug Pricing In Cost-Effectiveness Analyses Under The IRA
The American Journal of Managed Care
Varied Use of Step Therapy Among Medicare Advantage Plans
The Milbank Quarterly
Improving Food and Drug Administration–Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval
Cost Effectiveness and Resource Allocation
Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol